Landscape Capital Management’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-15,998
Closed -$613K – 842
2026
Q2
$613K Sell
15,998
-91,218
-85% -$2.39M 0.04% 464
2026
Q1
$2.28M Buy
107,216
+55,717
+108% +$1.11M 0.14% 221
2025
Q4
$840K Sell
51,499
-19,570
-28% -$296K 0.06% 390
2025
Q3
$831K Buy
+71,069
New +$927K 0.05% 393
2019
Q4
– Sell
-17,676
Closed -$891K – 830
2019
Q3
$891K Buy
+17,676
New +$978K 0.07% 295

Other funds holding TXG

Landscape Capital Management's TXG Position: Q3 2026 in Review

Landscape Capital Management sold out of 10x Genomics (TXG) in Q3 2026, closing a stake of 15,998 shares — an estimated $613K sold.

Landscape Capital Management first reported a position in TXG in Q3 2019 and held it in 5 quarters. The position peaked at $2.28M in Q1 2026. 494 funds tracked by Wall St. Rank hold TXG as of Q3 2026.

  • Landscape Capital Management reported no remaining 10x Genomics position as of Q3 2026 after selling out during the quarter.
  • Landscape Capital Management sold 15,998 10x Genomics shares in Q3 2026, an estimated $613K.
  • Landscape Capital Management first reported a position in 10x Genomics in Q3 2019 and held it in 5 quarters.
  • Landscape Capital Management's 10x Genomics position peaked at $2.28M in Q1 2026.
  • 494 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2026.

Based on Landscape Capital Management's 13F filing for Q3 2026, filed 10 Nov 2026.